ALNYLAM PHARMACEUTICALS INC

ALNY is the ticker symbol for Alnylam Pharmaceuticals, Inc., a biotechnology company. The stock trades on the Nasdaq Global Select Market. Alnylam focuses on RNA interference (RNAi) therapeutics, a class of drugs that can silence specific genes. Investors track ALNY as a way to gain exposure to the growing RNAi field and the company's pipeline of approved and investigational medicines.

Clinical trial outcomes, regulatory decisions, and drug commercialization progress heavily influence ALNY. Changes in reimbursement, competitive therapies, and pipeline setbacks also matter. Broader market conditions, interest rates, and sector sentiment can affect biotech stocks. Additionally, partnership or licensing news and quarterly financial results may move the shares. Investors should monitor company press releases and SEC filings for material updates.

Recent performance for ALNY fluctuates with market conditions, clinical developments, and financial results. For the latest price changes, daily moves, and period returns, please refer to the current ALNY stock data displayed on this page. That section provides up-to-date performance figures, including percentage changes over various time frames.

Because Alnylam is a biotech company focused on growth, traditional metrics like the P/E ratio may be less useful if earnings are negative or volatile. Investors often look at price-to-sales, price-to-book, or cash flow measures, and compare these with peers. Pipeline potential, revenue growth, and profitability timelines also matter. For current valuation metrics, see the latest ALNY data on this page.

To buy ALNY stock, you need a brokerage account that offers access to U.S. markets. You can place an order through the brokerage's platform using the ticker ALNY. Orders can be market or limit orders, depending on your preferences. Fractional shares may be available at some brokers, allowing you to invest smaller amounts. Check your broker's fees and order types before trading.

Start by reviewing Alnylam's investor relations website, which provides earnings reports, SEC filings, and press releases. Financial data platforms can offer ratios, price history, and peer comparisons. News about clinical trials and regulatory milestones is also valuable. For current price, market cap, and other live metrics, rely on the latest ALNY data displayed on this page.